DCM
ANAC

DAFNA Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

DAFNA Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-106,993
Closed -$598K – 57
2013
Q2 		$598K Buy
+106,993
New +$648K 0.88% 32

Other funds holding ANAC

RCP
Rho Capital Partners New York $20.4M AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

DAFNA Capital Management's ANAC Position: Q3 2013 in Review

DAFNA Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q3 2013, closing a stake of 106,993 shares — an estimated $598K sold.

DAFNA Capital Management first reported a position in ANAC in Q2 2013 and held it in 1 quarter. The position peaked at $598K in Q2 2013. 78 funds tracked by Wall St. Rank hold ANAC as of Q3 2013.

  • DAFNA Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q3 2013 after selling out during the quarter.
  • DAFNA Capital Management sold 106,993 ANACOR PHARMACEUTICALS INC COM shares in Q3 2013, an estimated $598K.
  • DAFNA Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 1 quarter.
  • DAFNA Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $598K in Q2 2013.
  • 78 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q3 2013.

Based on DAFNA Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.